Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
Results of a small clinical trial suggest that pycnogenol may provide some benefit for people suffering from Restless Legs Syndrome (RLS), a difficult-to-manage condition associated with increased cardiovascular risk. In a non-blinded and non-randomized trial, otherwise healthy adults with RLS (mean age 44) were given either 150mg pycnogenol per day (n=21) along with standard therapy (ST), or ST alone (n=24). ST included regular rest, mild exercise, and B&C vitamin supplementation) over a 4-week period.
While non-significant improvements were noted in the group only receiving standard therapy, the pycnogenol group had significant improvement in many symptoms of RLS. For example, 63% experienced less throbbing, 72% less aching, 61% had decreased sleep problems, etc., vs. 6%, 3%, and 16%, respectively in the ST alone group. The pycnogenol group also had a significant reduction in the need for pain medication, as well as improvement in several other markers including a normalization in resting flux and an increase in the venoarteriolar response, as well as a reduction in oxidative stress.
While obvious limitations of this study include the lack of blinding and of a placebo group, the large symptomatic improvements warrant a well-controlled study and reflect a previous clinical trial that demonstrated a clinical benefit of antioxidant therapy in RLS.
Submit this form and you'll receive our latest news and updates.
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment